3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
8
Observational
1
Expanded_access
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
1
Interventions
Ga(III)-DOTATOC
2
surufatinib
1
lutetium Lu 177 dotatate
1
Gallium-68
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Neuroendocrine Tumors
×
surufatinib
×
Clear all
NCT04814732
2024-04-12
Expanded Access Program of Surufatinib
Hutchmed
No longer available